Conformal coating by multilayer nano-encapsulation for the protection of human pancreatic islets: In-vitro and in-vivo studies

Nanomedicine. 2018 Oct;14(7):2191-2203. doi: 10.1016/j.nano.2018.06.013. Epub 2018 Jul 23.

Abstract

To improve the efficiency of pancreatic islet transplantation, we performed in-vitro and in-vivo experiments with isolated human pancreatic islets coated by multi-layer nano-encapsulation using differently charged polymers [chitosan and poly(sodium styrene sulfonate)] to obtain up to 9 layers. The islet coating (thickness: 104.2 ± 4.2 nm) was uniform, with ≥ 90% cell viability and well preserved beta- and alpha-cell ultrastructure. Nano-encapsulated islets maintained physiological glucose-stimulated insulin secretion by both static incubation and perifusion studies. Notably, palmitate- or cytokine-induced toxicity was significantly reduced in nano-coated islets. Xenotransplantation of nano-encapsulated islets under the kidney capsule of streptozotocin-induced C57Bl/6J diabetic mice allowed long term normal or near normal glycemia, associated with minimal infiltration of immune cell into the grafts, well preserved islet morphology and signs of re-vascularization. In summary, the multi-layer nano-encapsulation approach described in the present study provides a promising tool to effectively protect human islets both in-vitro andin-vivo conditions.

Keywords: Diabetes; Human islets; Immune isolation; Islets transplantation; Multilayer nanoencapsulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Cells, Cultured
  • Coated Materials, Biocompatible / chemistry*
  • Diabetes Mellitus, Experimental / prevention & control*
  • Humans
  • Islets of Langerhans / cytology*
  • Islets of Langerhans Transplantation*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nanostructures / administration & dosage*
  • Nanostructures / chemistry
  • Transplantation, Heterologous

Substances

  • Blood Glucose
  • Coated Materials, Biocompatible